Val
—
Gro
—
Qua
—
Mom
—
Sta
—
Cap—
P/S1.86
P/E—
Fwd P/E12.49
PEG1.22
52W— – —
RSI—
Target$84.69 (-4.4%)
Beta0.72
Div—
Loading chart…
RSI (14)
Loading patterns…
Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment offers solutions, such as negative pressure wound therapy, advanced wound dressings, advanced skin care, synthetic tissue matrices, I.V. site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers. The Dental Solutions segment provides dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents to span the life of the tooth, and products for preventative dental care, direct and indirect restoration, and orthodontic needs. The Health Information Systems segment offers healthcare systems with software solutions comprising computer-assisted physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms. The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce. Solventum Corporation was incorporated in 2023 and is headquartered in Eagan, Minnesota.
52-Week Range
52W Low
—
52W High
Position in Range
—
RSI (14)
0 · Oversold
RSI 72
Overbought · 100
Signal
Overbought
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
3Bullish
0Bearish
0Neutral
▲ Bull Flag — Breakout after +8% pole — bullish continuation
▲ Bull Flag — Breakout after +13% pole — bullish continuation
▲ Double Bottom — Two lows ~$73.90 — bullish reversal confirmed
View overlays on the price chart via Chart tab → Pattern Overlays.
EPS — History & Forecast
Estimate
Beat
Miss
Forecast
Loading…
Revenue — History & Forecast
Revenue
Forecast
Loading…
EPS Beat Rate
100%
8/8 quarters
Wall Street Consensus
BUY
BuyHoldSell
Price Target Range
$84.69
-4.4% upside
Low $60
—
High $100
Consensus
Current price
Wall Street Analyst Ratings
| Firm | Rating | Change | Action | Date |
|---|---|---|---|---|
| UBS | Buy | Neutral → Buy | ▲ Upgrade | 2026-07-28 |
| BMO Capital | Market Perform | — | ● Initiate | 2026-07-09 |
| Wedbush | Outperform | — | ● Initiate | 2026-05-15 |
| Stifel | Buy | — | ↔ Maintain | 2026-05-06 |
| Wells Fargo | Equal-Weight | — | ↔ Maintain | 2026-05-06 |
| Keybanc | Overweight | — | ↔ Maintain | 2026-05-06 |
| BTIG | Buy | — | ↔ Reiterate | 2026-05-06 |
| Piper Sandler | Overweight | — | ↔ Maintain | 2026-04-17 |
| Rothschild & Co | Sell | — | ● Initiate | 2026-03-24 |
| Mizuho | Outperform | Neutral → Outperform | ▲ Upgrade | 2026-01-20 |
UBS
2026-07-28
Buy
(from Neutral)
▲ Upgrade
BMO Capital
2026-07-09
Market Perform
● Initiate
Wedbush
2026-05-15
Outperform
● Initiate
Stifel
2026-05-06
Buy
↔ Maintain
Wells Fargo
2026-05-06
Equal-Weight
↔ Maintain
Keybanc
2026-05-06
Overweight
↔ Maintain
BTIG
2026-05-06
Buy
↔ Reiterate
Piper Sandler
2026-04-17
Overweight
↔ Maintain
Rothschild & Co
2026-03-24
Sell
● Initiate
Mizuho
2026-01-20
Outperform
(from Neutral)
▲ Upgrade
Profitability
Gross Margin
53.65%TTM
Op. Margin
5.58%TTM
ROE
34.79%TTM
Rev. Growth
-3.00%YoY
Free Cash Flow
377.50MTTM
FCF Yield
—TTM
Balance Sheet
Debt / Equity
106.48MRQ
Current Ratio
1.07MRQ
Cash
561.00MMRQ
Total Debt
5.29BMRQ
Net Debt
—MRQ
How SOLV Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
| Quarter | Revenue | Rev YoY | Gross Profit | Op. Income | Net Income | Net YoY | Gross % | Op % | Net % |
|---|
Full Key Statistics
Valuation
| Market Cap | 15.33B |
| Enterprise Value | 20.06B |
| Trailing P/E | 10.55 |
| Forward P/E | 12.49 |
| PEG Ratio (5yr) | 1.22 |
| Price/Sales (ttm) | 1.86 |
| Price/Book (mrq) | 3.09 |
| EV/Revenue | 2.43 |
| EV/EBITDA | 17.85 |
Share Statistics
| Avg Vol (3m) | 1.70M |
| Shares Outstanding | 173.17M |
| Float | 147.07M |
| % Held by Insiders | 15.07% |
| % Held by Institutions | 76.31% |
| Short Ratio | 3.34 |
| Short % of Float | 2.92% |
Profitability
| Gross Margin | 53.65% |
| Operating Margin (ttm) | 5.58% |
| Profit Margin | 17.33% |
| Return on Assets (ttm) | 2.75% |
| Return on Equity (ttm) | 34.79% |
Income Statement
| Revenue (ttm) | 8.26B |
| Revenue Growth (yoy) | -3.00% |
| Gross Profit (ttm) | 4.43B |
| EBITDA | 1.12B |
| Net Income (ttm) | 1.43B |
| Diluted EPS (ttm) | 8.39 |
| EPS Growth (yoy) | -91.00% |
Balance Sheet
| Total Cash (mrq) | 561.00M |
| Total Debt (mrq) | 5.29B |
| Debt / Equity (mrq) | 106.48 |
| Current Ratio (mrq) | 1.07 |
| Book Value / Share | 28.64 |
| Operating CF (ttm) | 151.00M |
| Free Cash Flow (ttm) | 377.50M |
Trading & Dividends
| Beta (5Y) | 0.72 |
| 50-Day MA | 77.94 |
| 200-Day MA | 75.11 |
| Fwd Dividend Yield | N/A |
| Payout Ratio | 0.00% |
Ownership Breakdown
Institutional 76.31%
Insider 15.07%
Public 8.6%
Short Interest
2.92% of float
Low
Institutional 13F Holdings
Famous investors who disclosed a position in SOLV in their latest SEC 13F filing.
Loading…
Insider Transactions
| Date | Insider | Role | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-13 | MCMILLAN WAYDE D | Chief Financial Officer | 9,503 | — | |
| 2026-05-13 | HANSON BRYAN CRAIG | Chief Executive Officer | 34,315 | — | |
| 2026-05-13 | KIRBERGER MARCELA A. | Officer | 4,488 | — | |
| 2026-05-13 | GOMEZ TAMMY L | Officer | 3,960 | — | |
| 2026-05-13 | LANDUCCI AMY | Chief Technology Officer | 4,422 | — | |
| 2026-05-13 | WILCOX MARY T | Officer | 2,376 | — | |
| 2026-05-13 | HARRINGTON PAUL S | Officer | 3,960 | — | |
| 2026-04-30 | EISENBERG GLENN A | Director | 3,403 | — | |
| 2026-04-30 | HARRIS BERNARD A JR | Director | 3,403 | — | |
| 2026-04-30 | ALBAN CARLOS | Director | 3,403 | — | |
| 2026-04-30 | DEVORE SUSAN D | Director | 3,403 | — | |
| 2026-04-30 | WILSON DARRYL L | Director | 3,403 | — | |
| 2026-04-30 | MILY ELIZABETH | Director | 3,403 | — | |
| 2026-04-30 | WEILAND JOHN H | Director | 3,403 | — | |
| 2026-04-30 | COX CARRIE SMITH | Director | 4,916 | — | |
| 2026-04-30 | MAY KAREN J | Director | 3,403 | — | |
| 2026-04-30 | EDWARDS SHIRLEY ANN | Director | 3,403 | — | |
| 2026-04-30 | WENDELL AMY MCBRIDE | Director | 3,403 | — | |
| 2026-03-27 | EISENBERG GLENN A | Director | 1,980 | — | |
| 2026-03-27 | HARRIS BERNARD A JR | Director | 1,980 | — | |
| 2026-03-27 | MCBRIDE-WENDELL AMY A. | Director | 1,980 | — | |
| 2026-03-27 | ALBAN CARLOS | Director | 1,980 | — | |
| 2026-03-27 | DEVORE SUSAN D | Director | 1,980 | — | |
| 2026-03-27 | WILSON DARRYL L | Director | 1,980 | — | |
| 2026-03-27 | MILY ELIZABETH | Director | 1,980 | — |
MCMILLAN WAYDE D
Chief Financial Officer
2026-05-13
9,503 sh
—
HANSON BRYAN CRAIG
Chief Executive Officer
2026-05-13
34,315 sh
—
KIRBERGER MARCELA A.
Officer
2026-05-13
4,488 sh
—
GOMEZ TAMMY L
Officer
2026-05-13
3,960 sh
—
LANDUCCI AMY
Chief Technology Officer
2026-05-13
4,422 sh
—
WILCOX MARY T
Officer
2026-05-13
2,376 sh
—
HARRINGTON PAUL S
Officer
2026-05-13
3,960 sh
—
EISENBERG GLENN A
Director
2026-04-30
3,403 sh
—
HARRIS BERNARD A JR
Director
2026-04-30
3,403 sh
—
ALBAN CARLOS
Director
2026-04-30
3,403 sh
—
DEVORE SUSAN D
Director
2026-04-30
3,403 sh
—
WILSON DARRYL L
Director
2026-04-30
3,403 sh
—
MILY ELIZABETH
Director
2026-04-30
3,403 sh
—
WEILAND JOHN H
Director
2026-04-30
3,403 sh
—
COX CARRIE SMITH
Director
2026-04-30
4,916 sh
—
MAY KAREN J
Director
2026-04-30
3,403 sh
—
EDWARDS SHIRLEY ANN
Director
2026-04-30
3,403 sh
—
WENDELL AMY MCBRIDE
Director
2026-04-30
3,403 sh
—
EISENBERG GLENN A
Director
2026-03-27
1,980 sh
—
HARRIS BERNARD A JR
Director
2026-03-27
1,980 sh
—
MCBRIDE-WENDELL AMY A.
Director
2026-03-27
1,980 sh
—
ALBAN CARLOS
Director
2026-03-27
1,980 sh
—
DEVORE SUSAN D
Director
2026-03-27
1,980 sh
—
WILSON DARRYL L
Director
2026-03-27
1,980 sh
—
MILY ELIZABETH
Director
2026-03-27
1,980 sh
—